UK market access Archives -

NHS England takes charge on market access

https://pharmaphorum.com/views-analysis-market-access/perjeta-benefits-nhs-england-takes-charge/

BI drug named Promising Innovative Medicine in mesothelioma

https://pharmaphorum.com/news/bi-drug-named-promising-innovative-medicine-mesothelioma/

Janssen’s Imbruvica runs into trouble with NICE in mantle cell lymphoma

https://pharmaphorum.com/news/imbruvica-mantle-cell-lymphoma/

Sanofi’s blockbuster-tipped Dupixent set for European launches

https://pharmaphorum.com/news/sanofis-blockbuster-tipped-dupixent-set-european-launches/

After a year’s delay, BMS seals Opdivo lung cancer deal with NICE

https://pharmaphorum.com/news/lung-cancer-patients-england-get-opdivo-bms-deal-nice/

Roche hails 4 year NICE access deal for Gazyvaro

https://pharmaphorum.com/news/roche-hails-4-year-nice-access-deal-gazyvaro/

Will UK patients get access to novel drugs?

https://pharmaphorum.com/views-and-analysis/will-uk-patients-get-access-to-novel-drugs/

Lilly’s sarcoma drug Lartruvo recommended via Cancer Drugs Fund

https://pharmaphorum.com/news/lillys-sarcoma-drug-lartruvo-recommended-via-cancer-drugs-fund/

https://pharmaphorum.com/news/amgens-myeloma-treatment-kyprolis-gains-nice-approval/

Search